Evidence map›Paper›PMID 39006467›Full record

ReviewHeart international2024

Transcatheter Tricuspid Valve Intervention for the Treatment of Tricuspid Regurgitation with TriClip: All You Need to Know.

Kamal Matli, Georges Namnoum, Soad Al-Osta, Alaa Masri, Aurelie Veugeois, Christelle Diakov, Christophe Caussin, Georges Ghanem

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kamal MatliDivision of Cardiology, Department of Medicine, University of Montreal Hospital Centre, Montreal, Quebec, Canada.
Georges NamnoumCardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.
Soad Al-OstaCardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.
Alaa MasriDepartment of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
Aurelie VeugeoisDepartment of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
Christelle DiakovDepartment of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
Christophe CaussinDepartment of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
Georges GhanemCardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe tricuspid regurgitation (TR) is a common pathology in the daily practice of a cardiologist. This disease entity is associated with significant morbidity and mortality if left untreated. Classically, surgical repair or replacement were the only therapeutic options present and were often not performed due to high postprocedural mortality. Transcatheter tricuspid valve intervention has emerged as a novel and effective therapeutic option for the treatment of significant TR. Several devices have been developed with different mechanisms of action. In this review, we will provide an overview of transcatheter edge-to-edge repair of TR using the TriClip device (Abbott, Santa Clara, CA, USA).

Indexed as

Cardiologytranscatheter tricuspid valve interventiontricuspid incompetencetricuspid regurgitationtricuspid valvevalvular heart disease

Identifiers

PMID39006467
PMCPMC11239132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.